Connective Tissue Disorders NGS Panel

Key Information

TAT:

8 weeks

Price:

$3,000

CPT Code(s):

81410

Test Code:

DCTP

Connective Tissue Disorders NGS Panel

The Connective Tissue Disorders NGS Panel is a 36-gene panel intended for patients with a diagnosis or clinical suspicion of a connective tissue disorder.

ABCC6, ACTA2, ACVR1, ADAMTS2, ATP6V0A2, ATP7A, CBS, CHST14, COL11A1, COL1A1, COL1A2, COL2A1, COL3A1, COL5A1, COL5A2, ELN, FBLN5, FBN1, FBN2, FKBP14, MOCS1, MYH11, MYLK, NOTCH1, PKD2, PLOD1, PRDM5, SKI, SLC2A10, SLC39A13, SMAD3, TGFB2, TGFBR1, TGFBR2, TNXB, ZNF469

Acromicric dysplasia, Adams-Oliver syndrome, Arterial tortuosity syndrome, Arthrochalasia Ehlers-Danlos syndrome, Brittle cornea syndrome, Congenital contractural arachnodactyly, Cutis laxa, Czech dysplasia\, metatarsal type, Ehlers-Danlos syndrome, Familial bicuspid aortic valve, Familial thoracic aortic aneurysm, Fibrodysplasia ossificans progressiva, Homocystinuria, Loeys-Dietz syndrome, Marfan syndrome, Megacystis-microcolon-intestinal hypoperistalsis syndrome, Menkes disease, Molybdenum cofactor deficiency, Musculocontractural Ehlers-Danlos syndrome, Osteoarthritis with mild chondrodysplasia, Osteogenesis imperfecta, Pseudoxanthoma elasticum, Shprintzen-Goldberg syndrome, Stickler syndrome, Supravalvular aortic stenosis

Clinical Information

This panel consists of 36 genes associated with various forms of connective tissue disorders. Many patients with a suspected connective tissue disorder will present with similar features due to the clinical variability and the variable expressivity among this group of disorders. Making the specific diagnosis can be important in determining the appropriate medical management for features such as aortic dilatation or abnormal wound healing.

Technical Information

This panel is performed by Next Generation Sequencing and covers the coding regions of the listed genes and the flanking intronic sequences. Promoter, 3′ untranslated sequences, and deep intronic sequences are also covered, but only known disease-causing variants in these regions will be reported. Variants identified on the panel are confirmed with Sanger sequencing if they do not meet certain quality thresholds.

Large deletions and duplications (CNVs) affecting the genes of the panel can be detected; however, due to defined settings in the analysis software, CNVs smaller than 2-kb may not be identified (for example, some small exonic level copy number changes may not be identified). Please note that certain types of genetic alterations including trinucleotide repeat expansions, methylation abnormalities, and balanced rearrangements (e.g., inversions, reciprocal translocations) may not be detected by the current analysis.

Specimen Requirements

  • The preferred sample type is 3-4 ml of peripheral blood collected in an EDTA (purple top) tube. Extracted DNA and saliva are also accepted for this test. Blood and saliva kits are available by request.
  • Send approximately 5µg of extracted DNA at a requested concentration of 90-130 ng/µl.
  • If saliva is submitted, and the extracted DNA is below quality control, then you will be contacted to submit a blood sample or the panel can be completed on an exome backbone. Saliva samples must be submitted in an approved saliva kit.

Transport Instructions

  • The blood specimen should be kept at room temperature and delivered via overnight shipping. If shipment is delayed by one or two days, the specimen should be refrigerated and shipped at room temperature. Do not freeze the specimen. Samples collected on Friday can be safely designated for Monday delivery.
  • Extracted DNA should be sent at room temperature via overnight delivery.
  • Saliva is stable at room temperature and can be delivered via overnight or ground shipping.

Connect With Our Experts

Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.

Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC